Last updated 4 days ago

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

1000 patients around the world
Available in Puerto Rico, Spain, Brazil, United States
AbbVie
16Research sites
1000Patients around the world
This study is for people with
Lupus
Systemic lupus erythematosus
Requirements for the patient
To 63 Years
All Gender
Medical requirements
Sites
Organización Médica de Investigación (OMI)
Uruguay 725 PB , Buenos Aires, CP: 1015
Fundación Sanatorio Güemes - CABA, Buenos Aires
Fundación Sanatorio Güemes - CABA, Buenos Aires
Fco Acuña de Figueroa 1228
CER Instituto Médico - Quilmes, Buenos Aires
CER Instituto Médico - Quilmes, Buenos Aires
Av. Vicente Lopez 1441, Quilmes, Buenos Aires
Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich
Av. Luis Maria Campos 726, CABA, Buenos Aires
Instituto CAICI - Rosario, Santa Fe
Mendoza 2612, Rosario, Santa Fe
Centro de Investigaciones Médicas Tucumán
Lavalle 506, T4000 San Miguel de Tucumán, Tucumán, Argentina
Instituto Médico Especializado (IME)
Hidalgo 568, CABA, Buenos Aires
Fundación CIDEA - Buenos Aires
Fundación CIDEA - Buenos Aires
Paraguay 2035, C1121ABE Cdad. Autónoma de Buenos Aires, Argentina
Aprillus Asistencia e Investigación
Terrada 89, Flores, CABA
Hospital Italiano de La Plata
Av. 51 entre 29 y 30 Nro 1725, La Plata, Buenos Aires
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy